An Open-Label, Randomized, Single-Dose, Crossover, Comparative Pharmacokinetics Study of YLB113 and the Etanercept Reference Product in Healthy Adult Male Subjects

被引:0
|
作者
Mustafa Shennak
Rana Al-Jaouni
Santhosh Kshirasagar
Ravi Sekhar Kasibhatta
Neelima Godse
Ahmad Al-Ghazawi
Praveen Vittala
Dhananjay Bakhle
机构
[1] Triumpharma,
[2] Lupin Limited,undefined
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:467 / 475
页数:8
相关论文
共 50 条
  • [1] An Open-Label, Randomized, Single-Dose, Crossover, Comparative Pharmacokinetics Study of YLB113 and the Etanercept Reference Product in Healthy Adult Male Subjects
    Shennak, Mustafa
    Al-Jaouni, Rana
    Kshirasagar, Santhosh
    Kasibhatta, Ravi Sekhar
    Godse, Neelima
    Al-Ghazawi, Ahmad
    Vittala, Praveen
    Bakhle, Dhananjay
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2020, 45 (04) : 467 - 475
  • [2] An open-label, randomized, single dose, comparative pharmacokinetics study of YLB113 and the etanercept reference product in healthy adult male subjects
    Al-Ghazawi, Ahmad
    Khirasagar, Santhosh
    Kasibhatta, Ravi Sekhar
    Godse, Neelima
    Al-Ghazawi, Ahmad
    Bakhle, Dhananjay
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 86 (06) : 1205 - 1206
  • [3] Pharmacokinetics and Bioequivalence of Misoprostol Tablets: An Open-Label, Randomized, Single-dose, Crossover Study With Healthy Chinese Volunteers
    Wang, Shumin
    Wu, Feng
    Han, Ying
    Ni, Siyang
    Guo, Shaojie
    Dai, Yuyang
    Xia, Qiang
    Chang, Di
    Zhang, Ju
    Wei, Huiwen
    Zhao, Xiuli
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (08): : 949 - 956
  • [4] Effects of Food and Antacids on the Pharmacokinetics of Eltrombopag in Healthy Adult Subjects: Two Single-Dose, Open-Label, Randomized-Sequence, Crossover Studies
    Williams, Daphne D.
    Peng, Bin
    Bailey, Christine K.
    Wire, Mary B.
    Deng, Yanli
    Park, Jung Wook
    Collins, David A.
    Kapsi, Shiva G.
    Jenkins, Julian M.
    CLINICAL THERAPEUTICS, 2009, 31 (04) : 764 - 776
  • [5] Pharmacokinetics, safety, and tolerability of sulcardine sulfate: an open-label, single-dose, randomized study in healthy Chinese subjects
    Chen, Qian
    Qian, Hong-jie
    Wang, Wei
    Zhang, Meng-qi
    Lu, Dong-ying
    Lu, Chuan
    Jin, Jie-mei
    Hu, Chao-ying
    Liu, Gang-yi
    Jia, Jing-ying
    Zheng, Hong-chao
    Li, Xue-ning
    Yu, Chen
    Wang, Yi-ping
    Liu, Yun
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 (01) : 120 - 125
  • [6] A Comparative Study to Assess the Efficacy, Safety, and Immunogenicity of YLB113 and the Etanercept Reference Product for the Treatment of Patients with Rheumatoid Arthritis
    Yamanaka, Hisashi
    Kamatani, Naoyuki
    Tanaka, Yoshiya
    Hibino, Toshihiko
    Drescher, Edit
    Sanchez-Burson, Juan
    Rettenbacher, Manfred
    Bhatia, Girish
    Gadve, Snehal
    Shah, Chirag
    Bakhle, Dhananjay
    RHEUMATOLOGY AND THERAPY, 2020, 7 (01) : 149 - 163
  • [7] Comparative Pharmacokinetics and Tolerability of Branded Etanercept (25 mg) and Its Biosimilar (25 mg): A Randomized, Open-Label, Single-Dose, Two-Sequence, Crossover Study in Healthy Korean Male Volunteers
    Gu, Namyi
    Yi, SoJeong
    Kim, Tae-Eun
    Kim, JaeWoo
    Shin, Sang-Goo
    Jang, In-Jin
    Yu, Kyung-Sang
    CLINICAL THERAPEUTICS, 2011, 33 (12) : 2029 - 2037
  • [8] Pharmacokinetics of a telmisartan/rosuvastatin fixed-dose combination: a single-dose, randomized, open-label, 2-period crossover study in healthy Korean subjects
    Chae, Dong Woo
    Son, Mijeong
    Kim, Yukyung
    Son, Hankil
    Jang, Seong Bok
    Seo, Jeong Min
    Nam, Su Youn
    Park, Kyungsoo
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2015, 53 (10) : 883 - 889
  • [9] Pharmacokinetics of Rosuvastatin/Olmesartan Fixed-Dose Combination: A Single-Dose, Randomized, Open-Label, 2-Period Crossover Study in Healthy Korean Subjects
    Son, Hankil
    Roh, Hyerang
    Lee, Donghwan
    Chang, HeeChul
    Kim, JunKu
    Yun, Chohee
    Park, Kyungsoo
    CLINICAL THERAPEUTICS, 2013, 35 (07) : 915 - 922
  • [10] A Comparative Study to Assess the Efficacy, Safety, and Immunogenicity of YLB113 and the Etanercept Reference Product for the Treatment of Patients with Rheumatoid Arthritis
    Hisashi Yamanaka
    Naoyuki Kamatani
    Yoshiya Tanaka
    Toshihiko Hibino
    Edit Drescher
    Juan Sánchez-Bursón
    Manfred Rettenbacher
    Girish Bhatia
    Snehal Gadve
    Chirag Shah
    Dhananjay Bakhle
    Rheumatology and Therapy, 2020, 7 : 149 - 163